AlphaGalileo9h
Minimally Invasive Valve Repair Reduces Heart Failure Hospitalizations in Patients with Severe Tricuspid Regurgitation
At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available medical therapy plus a ...
MedPage Today8h
Evolut Low Risk TAVR Still Chugging Along, Now Halfway to Trial's Finish Line
CHICAGO -- Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery for younger patients at ...
MassDevice13h
Medtronic says Evolut TAVR shows durable five-year outcomes in low-risk patients
Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...
Healio12h
TAVR remains noninferior to surgery for low-risk patients at 5 years
Among patients with severe aortic stenosis at low surgical risk, transcatheter aortic valve replacement and surgery conferred ...
TCTMD7h
Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years
The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...
MedPage Today9h
Cerebral Embolic Protection for TAVI Doesn't Cut Strokes, Trial Affirms
Incidence of stroke within 72 hours after TAVI or before discharge, if sooner, came out a similar 2.1% with and 2.2% without ...
The New York Times14h
New York Times - Top Stories
The Secret History of America’s Role in the Ukraine War Part 1 Building Trust — and a Killing Machine Part 2 ‘When You Defeat Russia, We Will Make You Blue for Good’ Part 3 ...